Nanospheres: A novel approach for targeted drug delivery system

International Journal of Pharmaceutical Sciences Review and Research

Volumn 5, Issue 3, 2010, Pages 84-88

  Singh, Amit ^a   Garg, Garima ^a   Sharma, P K ^a  

^a MEERUT INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

Drug delivery; Drug targeting; Nanospheres; Opsonization; RES

Indexed keywords

ANTINEOPLASTIC AGENT; MACROGOL; NANOSPHERE; POLYSORBATE 80;

ARTICLE; BIOAVAILABILITY; BLOOD BRAIN BARRIER; CHEMICAL REACTION; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENZYME DEGRADATION; HUMAN; NANOENCAPSULATION; NANOTECHNOLOGY; PARTICLE SIZE; PHASE INVERSION TEMPERATURE METHOD; POLYMERIZATION; SOLVENT DISPLACEMENT TECHNIQUE; SOLVENT EVAPORATION;

EID: 79952054306     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Mohan raj VJ, Chen Y. Nanoparticles - A review, Tropical Journal of Pharmaceutical Research, 5, 2006, 561-573.
2. Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory's experience, Accounts of Chemical Research, 33, 2000, 94-101.
3. Bhadra D, Bhadra S Jain, Jain NK. Pegnology: a review of PEG-ylated systems, Pharmazie, 57, 2002, 5-29.
4. Kommareddy S, Tiwari SB, Amiji MM. Longcirculating polymeric nanovectors for tumorselective gene delivery, Technology in Cancer Research and Treatment, 4, 2005, 615-25.
5. Lee M, Kim SW. Polyethylene glycol-conjugated copolymers for plasmid DNA delivery, Pharmaceutical Research, 22, 2005, 1-10.
6. Illum L, Davis S.S. The organ uptake of intravenously administered colloidal particles can be altered using a nonionic surfactant (Poloxamer 338), FEBS Lett, 167, 1984, 79-82.
7. Allen TM. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system, Advanced Drug Delivery Reviews, 13, 1994, 285-309.
8. Troeste SD, Kreuter J. Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly (methyl methacrylate) nanoparticles, Journal of Microencapsulation, 9, 1992, 19-28.
9. Mueller RH, Wallis KH. Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and Poloxamine 908, International Journal of Pharmaceutics, 89, 1993, 25-31.
10. Troester SD, Kreuter J. Contact angles of surfactants with a potential to alter the body distribution of colloidal drug carriers on poly (methyl methacrylate) surfaces, International Journal of Pharmaceutics, 45, 1988, 91-100.
11. Illum L, Hunneyball IM, Davis SS. The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages, International Journal of Pharmaceutics, 29, 1986, 53-65.
12. Vila A, Sanchez A, Tobio M, Calvo P and Alonso MJ. Design of biodegradable particles for protein delivery, Journal of Controlled Release, 78, 2002, 15-24.
13. Mu L, Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol(R)): PLGA nanoparticles containing vitamin E TPGS, Journal of Controlled Release, 86, 2003, 33-48.
14. Zonghua L, Yanpeng J, Yifei W, Changren Z, Ziyong Z. Polysaccharides-based nanoparticles as drug delivery systems, Advanced Drug Delivery Reviews, 60, 2008, 1650-1662.
15. Jung T, W. Kamm A, Breitenbach E, Kaiserling, and Xiao J.X, Kissel T. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?, European Journal of Pharmaceutics and Biopharmaceutics, 50, 2000, 147-160.
16. Illum L. Nanoparticulate systems for nasal delivery of drugs: a real Improvement over simple systems? Journal of Pharmaceutical Science, 96, 2007, 473-483.
17. Mohan raj VJ, Chen Y. Nanoparticles- a review, Tropical Journal of Pharmaceutical Research, 5, 2006, 561-573.
18. Zhang Q, Shen Z, Nagai T. Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats, International Journal of Pharmaceutics, 218, 2001, 75-80.
19. Boudad H, Legrand P, Lebas G, Cheron M, Duchene D, Ponchel G. Combined hydroxypropyl-[beta]- Cyclodextrins and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir, International Journal of Pharmaceutics, 218, 2001, 113-124.
20. Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles, Nanomedicine, 2, 2006, 8-21.
21. S Galindo-Rodriguez, E Allemann, H Fessi, and E Doelker. Physicochemical Parameters Associated with Nanoparticle Formation in the Salting-Out, Emulsification-Diffusion, and Nanoprecipitation Methods, Pharmaceutical Research, 2, 2004, 1428-1439.
22. Chiannilkulchai N, Ammoury N, Caillou B, Devissaguet JP, Couvreur P. Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice, Cancer Chemotherapy and Pharmacology, 26, 1990, 122-6.
23. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice, Pharmacological Reviews, 53, 2001, 283-318.
24. Storm G, Belliot S, Daemen T, Lasic D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system, Advanced Drug Delivery Reviews, 17, 1995, 31-48.
25. Torchilin V, Trubetskoy V. Which polymer can make nanoparticulate drug carriers long circulating? Advanced Drug Delivery Reviews, 16, 1995, 141-155.
26. Jeon SI, Lee JH, Andrade JD, De Gennes PG. Protein-- surface interactions in the presence of polyethylene oxide: I. Simplified theory, Journal of Colloid and Interface Science, 142, 1991, 149-158.
27. Jeon SI, Andrade JD. Protein--surface interactions in the presence of polyethylene oxide: II. Effect of protein size, Journal of Colloid and Interface Science, 142, 1991, 159-166.
28. Damge C, Michel C, Aprahamian M, Couvreur P, Devissaguet JP. Nanocapsules as carriers for oral peptide delivery, Journal of Controlled Release, 13, 1990, 233-239.
29. Chen Y, Dalwadi G, Benson H. Drug delivery across the blood-brain barrier, Current Drug Delivery, 1, 2004, 361-376.
30. Kreuter J. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain, Journal of Nanoscience and Nanotechnology, 4, 2004, 484-8.
31. Pardridge WM. Drug and gene targeting to the brain with molecular Trojan horses, Nature Reviews Drug Discovery, 1, 2002, 131-9.
32. Ji B, Maeda J, Higuchi M, Inoue K, Akita H, Harashima H, Suhara T. Pharmacokinetics and brain uptake of lactoferrin in rats, Life Sciences, 78, 2006, 851-855.
33. Scherrmann JM, Temsamani J. The use of Pep: Tran's vectors for the delivery of drugs into the central nervous system, International Congress Series, 1277, 2005, 199-211.
34. Gabathuler R, Arthur G, Kennard M, Chen Q, Tsai S, Yang J, Schoorl W, Vitalis TZ, and Jefferies WA. Development of a potential protein vector (NeuroTrans) to deliver drugs across the blood brain barrier, International Congress Series, 1277, 2005, 171-184.